Amy Schrader

634 total citations
18 papers, 478 citations indexed

About

Amy Schrader is a scholar working on Physiology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amy Schrader has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Rheumatology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amy Schrader's work include Dermatology and Skin Diseases (3 papers), Muscle metabolism and nutrition (3 papers) and Nutrition and Health in Aging (3 papers). Amy Schrader is often cited by papers focused on Dermatology and Skin Diseases (3 papers), Muscle metabolism and nutrition (3 papers) and Nutrition and Health in Aging (3 papers). Amy Schrader collaborates with scholars based in United States, India and South Korea. Amy Schrader's co-authors include Robert R. Wolfe, Horace J. Spencer, Il‐Young Kim, Scott Schutzler, Arny A. Ferrando, Gohar Azhar, Nicolaas E.P. Deutz, Patrick Kortebein, Teresa J. Hudson and Susan M. Paddock and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Physiology-Endocrinology and Metabolism and Journal of the American Academy of Dermatology.

In The Last Decade

Amy Schrader

17 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Schrader United States 10 304 249 138 51 45 18 478
Naílza Maestá Brazil 14 268 0.9× 105 0.4× 175 1.3× 59 1.2× 99 2.2× 31 568
Maike Rahn United States 12 173 0.6× 164 0.7× 164 1.2× 21 0.4× 53 1.2× 20 521
R.G. Memelink Netherlands 9 506 1.7× 209 0.8× 123 0.9× 29 0.6× 19 0.4× 19 622
Bernard Jandrain Belgium 12 154 0.5× 140 0.6× 43 0.3× 27 0.5× 50 1.1× 48 397
Giovanni D’Alicandro Italy 10 112 0.4× 53 0.2× 59 0.4× 100 2.0× 18 0.4× 15 356
Maurílio Tiradentes Dutra Brazil 12 203 0.7× 48 0.2× 55 0.4× 33 0.6× 51 1.1× 34 408
LS Piers Australia 8 326 1.1× 75 0.3× 159 1.2× 46 0.9× 18 0.4× 10 532
Hana Tannir Lebanon 13 326 1.1× 39 0.2× 153 1.1× 35 0.7× 12 0.3× 34 466
Carliene van Dronkelaar Netherlands 9 340 1.1× 97 0.4× 117 0.8× 13 0.3× 23 0.5× 13 417
James Gerofi Australia 9 333 1.1× 36 0.1× 143 1.0× 203 4.0× 58 1.3× 16 616

Countries citing papers authored by Amy Schrader

Since Specialization
Citations

This map shows the geographic impact of Amy Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Schrader more than expected).

Fields of papers citing papers by Amy Schrader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Schrader. The network helps show where Amy Schrader may publish in the future.

Co-authorship network of co-authors of Amy Schrader

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Schrader. A scholar is included among the top collaborators of Amy Schrader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Schrader. Amy Schrader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Harrold, Leslie R., Sheila Kelly, Xue Han, et al.. (2024). Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive. Advances in Rheumatology. 64(1). 10–10. 1 indexed citations
2.
Lebwohl, Mark, Bruce Strober, Amy Schrader, et al.. (2024). Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. Drugs - Real World Outcomes. 11(3). 451–464. 2 indexed citations
3.
Silverberg, Jonathan I., Evangeline Pierce, Amber Reck Atwater, et al.. (2023). Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry. Journal of Dermatological Treatment. 34(1). 2246601–2246601.
4.
Harrold, Leslie R., Patrick Zueger, W. Benjamin Nowell, et al.. (2023). A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis. Rheumatology and Therapy. 10(6). 1519–1533. 2 indexed citations
5.
6.
7.
Wu, Jashin J., Amy Schrader, Robert R. McLean, et al.. (2020). Improvement in body surface area is associated with better quality of life among patients with psoriasis in the Corrona Psoriasis Registry. Journal of the American Academy of Dermatology. 84(6). 1715–1717. 1 indexed citations
8.
Foster, Stephen R., et al.. (2017). Adaptations in the Age of Technology in Seniors. 1(1). 2 indexed citations
9.
10.
Watkins, Katherine E., Susan M. Paddock, Teresa J. Hudson, et al.. (2017). Association between process measures and mortality in individuals with opioid use disorders. Drug and Alcohol Dependence. 177. 307–314. 16 indexed citations
11.
Foster, Stephen R., et al.. (2017). Hydration health literacy in the elderly. PubMed. 4(3). 227–237. 41 indexed citations
12.
Kim, Il‐Young, Scott Schutzler, Amy Schrader, et al.. (2017). Protein intake distribution pattern does not affect anabolic response, lean body mass, muscle strength or function over 8 weeks in older adults: A randomized-controlled trial. Clinical Nutrition. 37(2). 488–493. 65 indexed citations
13.
Hepner, Kimberly A., Susan M. Paddock, Katherine E. Watkins, et al.. (2017). Association Between Quality Measures and Perceptions of Care Among Patients With Substance Use Disorders. Psychiatric Services. 68(11). 1150–1156. 4 indexed citations
14.
Paddock, Susan M., Kimberly A. Hepner, Teresa J. Hudson, et al.. (2017). Association Between Process Based Quality Indicators and Mortality for Patients With Substance Use Disorders. Journal of Studies on Alcohol and Drugs. 78(4). 588–596. 21 indexed citations
15.
Watkins, Katherine E., Susan M. Paddock, Teresa J. Hudson, et al.. (2016). Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders. Journal of Substance Abuse Treatment. 69. 1–8. 23 indexed citations
16.
Kim, Il‐Young, Scott Schutzler, Amy Schrader, et al.. (2015). The anabolic response to a meal containing different amounts of protein is not limited by the maximal stimulation of protein synthesis in healthy young adults. American Journal of Physiology-Endocrinology and Metabolism. 310(1). E73–E80. 91 indexed citations
17.
Kim, Il‐Young, Scott Schutzler, Amy Schrader, et al.. (2015). Acute ingestion of citrulline stimulates nitric oxide synthesis but does not increase blood flow in healthy young and older adults with heart failure. American Journal of Physiology-Endocrinology and Metabolism. 309(11). E915–E924. 49 indexed citations
18.
Kim, Il‐Young, Scott Schutzler, Amy Schrader, et al.. (2014). Quantity of dietary protein intake, but not pattern of intake, affects net protein balance primarily through differences in protein synthesis in older adults. American Journal of Physiology-Endocrinology and Metabolism. 308(1). E21–E28. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naílza Maestá Breakdown of academic impact, for papers by Maike Rahn Breakdown of academic impact, for papers by R.G. Memelink Breakdown of academic impact, for papers by Bernard Jandrain Breakdown of academic impact, for papers by Giovanni D’Alicandro Breakdown of academic impact, for papers by Maurílio Tiradentes Dutra Breakdown of academic impact, for papers by LS Piers Breakdown of academic impact, for papers by Hana Tannir Breakdown of academic impact, for papers by Carliene van Dronkelaar Breakdown of academic impact, for papers by James Gerofi
Rankless by CCL
2026